Clinical Trial: A Single-arm, Multicenter Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606937) titled 'A Single-arm, Multicenter Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.' on May 19.

Brief Summary: This study is a single-arm, multicenter, open-label clinical study evaluating the efficacy and safety of axicabtagene ciloleucel injection manufactured by an automated cell preparation process in adult subjects with relapsed or refractory large B-cell lymphoma (r/r LBCL) as second-line therapy.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory Large B-cell Lymphoma

Intervention: DRUG: FKC876 injection

CD19 CAR-T

Recruitment Status: RECRUITING

Sponsor: Shenzhen Fosun K...